Literature DB >> 30054393

Central Amygdala Circuits Mediate Hyperalgesia in Alcohol-Dependent Rats.

Elizabeth M Avegno1, Thomas D Lobell1, Christy A Itoga1, Brittni B Baynes1, Annie M Whitaker1, Marcus M Weera1, Scott Edwards1,2, Jason W Middleton3,2, Nicholas W Gilpin4,2.   

Abstract

Alcohol withdrawal symptoms contribute to excessive alcohol drinking and relapse in alcohol-dependent individuals. Among these symptoms, alcohol withdrawal promotes hyperalgesia, but the neurological underpinnings of this phenomenon are not known. Chronic alcohol exposure alters cell signaling in the central nucleus of the amygdala (CeA), and the CeA is implicated in mediating alcohol dependence-related behaviors. The CeA projects to the periaqueductal gray (PAG), a region critical for descending pain modulation, and may have a role in alcohol withdrawal hyperalgesia. Here, we tested the roles of (1) CeA projections to PAG, (2) CeA melanocortin signaling, and (3) PAG μ-opioid receptor signaling in mediating thermal nociception and alcohol withdrawal hyperalgesia in male Wistar rats. Our results demonstrate that alcohol dependence reduces GABAergic signaling from CeA terminals onto PAG neurons and alters the CeA melanocortin system, that CeA-PAG projections and CeA melanocortin signaling mediate alcohol withdrawal hyperalgesia, and that μ-opioid receptors in PAG filter CeA effects on thermal nociception.SIGNIFICANCE STATEMENT Hyperalgesia is commonly seen in individuals with alcohol use disorder during periods of withdrawal, but the neurological underpinnings behind this phenomenon are not completely understood. Here, we tested whether alcohol dependence exerts its influence on pain modulation via effects on the limbic system. Using behavioral, optogenetic, electrophysiological, and molecular biological approaches, we demonstrate that central nucleus of the amygdala (CeA) projections to periaqueductal gray mediate thermal hyperalgesia in alcohol-dependent and alcohol-naive rats. Using pharmacological approaches, we show that melanocortin receptor-4 signaling in CeA alters alcohol withdrawal hyperalgesia, but this effect is not mediated directly at synaptic inputs onto periaqueductal gray-projecting CeA neurons. Overall, our findings support a role for limbic influence over the descending pain pathway and identify a potential therapeutic target for treating hyperalgesia in individuals with alcohol use disorder .
Copyright © 2018 the authors 0270-6474/18/387761-13$15.00/0.

Entities:  

Keywords:  descending inhibition; electrophysiology; mu opioid receptors; optogenetics; pain

Mesh:

Substances:

Year:  2018        PMID: 30054393      PMCID: PMC6125812          DOI: 10.1523/JNEUROSCI.0483-18.2018

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  47 in total

1.  Presynaptic and postsynaptic relations of mu-opioid receptors to gamma-aminobutyric acid-immunoreactive and medullary-projecting periaqueductal gray neurons.

Authors:  K G Commons; S A Aicher; L M Kow; D W Pfaff
Journal:  J Comp Neurol       Date:  2000-04-17       Impact factor: 3.215

2.  Divergent Modulation of Nociception by Glutamatergic and GABAergic Neuronal Subpopulations in the Periaqueductal Gray.

Authors:  Vijay K Samineni; Jose G Grajales-Reyes; Bryan A Copits; Daniel E O'Brien; Sarah L Trigg; Adrian M Gomez; Michael R Bruchas; Robert W Gereau
Journal:  eNeuro       Date:  2017-03-29

3.  Increased pain sensitivity in alcohol withdrawal syndrome.

Authors:  Thomas Jochum; Michael K Boettger; Christin Burkhardt; Georg Juckel; Karl-Jürgen Bär
Journal:  Eur J Pain       Date:  2009-12-16       Impact factor: 3.931

4.  Dynorphin and stress-related peptides in rat locus coeruleus: contribution of amygdalar efferents.

Authors:  B A S Reyes; G Drolet; E J Van Bockstaele
Journal:  J Comp Neurol       Date:  2008-06-01       Impact factor: 3.215

5.  Periaqueductal gray afferents synapse onto dopamine and GABA neurons in the rat ventral tegmental area.

Authors:  Natalia Omelchenko; Susan R Sesack
Journal:  J Neurosci Res       Date:  2010-04       Impact factor: 4.164

6.  Central administration of selective melanocortin 4 receptor antagonist HS014 prevents morphine tolerance and withdrawal hyperalgesia.

Authors:  Annasaheb S Kalange; Dadasaheb M Kokare; Praful S Singru; Manoj A Upadhya; Chandrabhan T Chopde; Nishikant K Subhedar
Journal:  Brain Res       Date:  2007-09-04       Impact factor: 3.252

Review 7.  A role for brain stress systems in addiction.

Authors:  George F Koob
Journal:  Neuron       Date:  2008-07-10       Impact factor: 17.173

8.  GABAergic modulation of the analgesic effects of morphine microinjected in the ventral periaqueductal gray matter of the rat.

Authors:  A Depaulis; M M Morgan; J C Liebeskind
Journal:  Brain Res       Date:  1987-12-15       Impact factor: 3.252

9.  Ephus: multipurpose data acquisition software for neuroscience experiments.

Authors:  Benjamin A Suter; Timothy O'Connor; Vijay Iyer; Leopoldo T Petreanu; Bryan M Hooks; Taro Kiritani; Karel Svoboda; Gordon M G Shepherd
Journal:  Front Neural Circuits       Date:  2010-08-26       Impact factor: 3.492

10.  A Transgenic Rat for Investigating the Anatomy and Function of Corticotrophin Releasing Factor Circuits.

Authors:  Matthew B Pomrenze; E Zayra Millan; F Woodward Hopf; Ronald Keiflin; Rajani Maiya; Angelo Blasio; Jahan Dadgar; Viktor Kharazia; Giordano De Guglielmo; Elena Crawford; Patricia H Janak; Olivier George; Kenner C Rice; Robert O Messing
Journal:  Front Neurosci       Date:  2015-12-24       Impact factor: 4.677

View more
  40 in total

1.  Electroacupuncture Relieves Pain During Alcohol Withdrawal.

Authors:  Jiang-Hong Ye; Wanhong Zuo; Jing Li; Rao Fu; Daniel J Eloy; Alex Bekker
Journal:  Med Acupunct       Date:  2020-12-16

Review 2.  Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development.

Authors:  George F Koob
Journal:  Pharmacol Rev       Date:  2021-01       Impact factor: 25.468

3.  Cellular, circuit and transcriptional framework for modulation of itch in the central amygdala.

Authors:  Vijay K Samineni; Jose G Grajales-Reyes; Gary E Grajales-Reyes; Eric Tycksen; Bryan A Copits; Christian Pedersen; Edem S Ankudey; Julian N Sackey; Sienna B Sewell; Michael R Bruchas; Robert W Gereau
Journal:  Elife       Date:  2021-05-25       Impact factor: 8.140

Review 4.  Endogenous opioid peptides in the descending pain modulatory circuit.

Authors:  Elena E Bagley; Susan L Ingram
Journal:  Neuropharmacology       Date:  2020-05-15       Impact factor: 5.250

5.  Brain-wide functional architecture remodeling by alcohol dependence and abstinence.

Authors:  Adam Kimbrough; Daniel J Lurie; Andres Collazo; Max Kreifeldt; Harpreet Sidhu; Giovana Camila Macedo; Mark D'Esposito; Candice Contet; Olivier George
Journal:  Proc Natl Acad Sci U S A       Date:  2020-01-14       Impact factor: 11.205

6.  Central Amygdala Projections to Lateral Hypothalamus Mediate Avoidance Behavior in Rats.

Authors:  Marcus M Weera; Rosetta S Shackett; Hannah M Kramer; Jason W Middleton; Nicholas W Gilpin
Journal:  J Neurosci       Date:  2020-11-13       Impact factor: 6.167

Review 7.  Driving the Downward Spiral: Alcohol-Induced Dysregulation of Extended Amygdala Circuits and Negative Affect.

Authors:  Samuel W Centanni; Gaurav Bedse; Sachin Patel; Danny G Winder
Journal:  Alcohol Clin Exp Res       Date:  2019-08-30       Impact factor: 3.455

Review 8.  The predator odor avoidance model of post-traumatic stress disorder in rats.

Authors:  Lucas Albrechet-Souza; Nicholas W Gilpin
Journal:  Behav Pharmacol       Date:  2019-04       Impact factor: 2.293

9.  Cue-elicited functional connectivity of the periaqueductal gray and tonic cocaine craving.

Authors:  Sheng Zhang; Simon Zhornitsky; Wuyi Wang; Isha Dhingra; Thang M Le; Chiang-Shan R Li
Journal:  Drug Alcohol Depend       Date:  2020-08-19       Impact factor: 4.492

Review 10.  Amygdala, neuropeptides, and chronic pain-related affective behaviors.

Authors:  Volker Neugebauer; Mariacristina Mazzitelli; Bryce Cragg; Guangchen Ji; Edita Navratilova; Frank Porreca
Journal:  Neuropharmacology       Date:  2020-03-15       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.